Biomarkers Market By Types & By Application 2020 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Biomarkers market
Biomarkers Market: Types (Biomarkers: Disease & related, Imaging, Others) Application (Drug Discovery, Bioinformatics, Others) Therapeutic Areas (Cardiology, Neurology, Others) Products (Hormones, Enzymes, Others) End Users (Hospitals, Others)-Forecast(2015-2020)
Report Code : HCR 0059
Published: 07 August, 2015   No. of pages: 85

  • Report Description
  • Table of Contents
  • Customization Options
Biomarkers are biological molecules which act as indicator of a particular disease state or pharmacological conditions. Advancement in post genomic technologies, increasing R&D spending and dynamic applications of biomarkers in medicine will drive the future market growth.

The market for Biomarkers is classified into five categories based on types, application areas, therapeutic segments, products and by end users, each of these segments are further broken down into sub-segments to give a comprehensive analysis of global biomarkers market.

The overall market has also been presented from the perspective of different geographic locations and key economies in this market. Competitors are highlighted and market players are profiled with attributes covering company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of each of the prominent players for 2015 are detailed.

The market is largely dominated by North America which accounted for about half of the global share. APAC is a promising market and is opening gateways for new manufacturers.

The report also provides a detailed qualitative analysis of the factors responsible for driving and hindering the growth of the Biomarkers market and future opportunities that can propel the market.

The report contains the most detailed and in-depth segmentation and analysis of the Global Biomarkers Market during the forecast period 2015 - 2020.
1. Global Biomarkers Market – Market Overview
2. Executive Summary
3. Global Biomarkers Market - Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. Patent Analysis
      3.2.3. End user profiling
      3.2.4. Top 5 Financials Analysis
4. Biomarkers Market- Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Biomarkers Market - Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Opportunities Analysis
   5.3. Product lifecycle
   5.4. Pricing Analysis
6. Biomarkers Market- By Types
   6.1. Disease-related biomarkers
      6.1.1. Diagnostic biomarker
      6.1.2. Prognostic biomarker
   6.2. Drug-related biomarkers
   6.3. Imaging biomarkers
   6.4. Molecular biomarkers
   6.5. Surrogate biomarkers
   6.6. Others
7. Biomarkers Market- By Application
   7.1. Drug discovery & Development
   7.2. Molecular diagnostics
   7.3. Genetic studies
   7.4. Clinical Trials
   7.5. Bioinformatics
   7.6. Others
8. Biomarkers Market- By Therapeutic areas
   8.1. Oncology
   8.2. Cardiology
   8.3. Immunology
   8.4. Neurology
   8.5. Others
9. Global Biomarkers Market- By Products
   9.1. Hormones
   9.2. Enzymes
   9.3. Antibodies
   9.4. Gene products
   9.5. Others
10. Biomarkers Market- By End Users
   10.1. Pharmaceutical Companies
   10.2. Hospitals
   10.3. Research Institutes
   10.4. CROs
   10.5. Diagnostic Labs
11. Biomarkers Market -Geographic Analysis
   11.1. North America
      11.1.1. Canada
      11.1.2. Mexico
      11.1.3. USA
      11.1.4. Others
   11.2. Europe
      11.2.1. France
      11.2.2. Germany
      11.2.3. Italy
      11.2.4. Sweden
      11.2.5. U.K
      11.2.6. Others
   11.3. APAC
      11.3.1. China
      11.3.2. India
      11.3.3. Japan
      11.3.4. Australia
      11.3.5. Others
   11.4. ROW
      11.4.1. South Africa
      11.4.2. South America
      11.4.3. Russia
      11.4.4. Saudi Arabia
      11.4.5. Others
12. Market Entropy
   12.1. New Product Launches
   12.2. M&As, Collaborations, JVs and Partnerships
13. Company profiles
   13.1. Qiagen N.V.
   13.2. PerkinElmer, Inc.
   13.3. Merck & Co, Inc.
   13.4. Bio-Rad Laboratories
   13.5. Enzo Biochem
   13.6. EKF Diagnostics Holdings plc
   13.7. Meso Scale Diagnostics, LLC
   13.8. Singulex, Inc.
   13.9. BioSims Technologies
   13.10. Cisbio Bioassays
   13.11. Signosis, Inc.
   13.12. Roche Diagnostic Limited
   13.13. Siemens Healthcare
   13.14. Abbott Laboratories Inc.
   13.15. Thermo Fisher Scientific, Inc.
   13.16. Agilent Technologies Inc.
   13.17. Aushon BioSystem Inc.
   13.18. Epistem Ltd
   13.19. G.E. Healthcare Inc.
   13.20. Beckman Coulter, Inc.
   13.21. Biomoda, Inc.
   13.22. Epigenomics AG  
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
14. Appendix
   14.1. Abbreviations
   14.2. Sources
   14.3. Research Methodology
   14.4. Bibliography
   14.5. Compilation of Expert Insights
   14.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports